These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 35634680)
1. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity. Huang X; Cao Y; Bao P; Zhu B; Cheng Z Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Lin A; Gu T; Hu X; Zhang J; Luo P J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y Front Immunol; 2021; 12():665002. PubMed ID: 34367132 [TBL] [Abstract][Full Text] [Related]
4. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic impact of Yang K; Zhu T; Sheng C; Zhu J; Xu J; Fu G Transl Cancer Res; 2024 Sep; 13(9):4736-4751. PubMed ID: 39430839 [TBL] [Abstract][Full Text] [Related]
6. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma. Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338 [TBL] [Abstract][Full Text] [Related]
7. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3. Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153 [No Abstract] [Full Text] [Related]
8. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction. Wang Z; Niu D Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070 [TBL] [Abstract][Full Text] [Related]
9. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
10. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K Front Immunol; 2023; 14():1093974. PubMed ID: 36949947 [TBL] [Abstract][Full Text] [Related]
12. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
13. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. Wang H; Wang W; Wang Z; Li X Front Immunol; 2023; 14():1291859. PubMed ID: 38143740 [TBL] [Abstract][Full Text] [Related]
14. Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma. Zhou R; Sun Z; Zhou R; Wang M; Zhuo Q; Deng X; Wang Z; Xu Y Med Oncol; 2024 Oct; 41(11):285. PubMed ID: 39402288 [TBL] [Abstract][Full Text] [Related]
15. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
16. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma]. Zhao H; Liu G; Li Y; Yang N; Zhao J Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647 [TBL] [Abstract][Full Text] [Related]
17. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203 [No Abstract] [Full Text] [Related]
18. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
19. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H; Xing F BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131 [TBL] [Abstract][Full Text] [Related]
20. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]